Skip to main content
Premium Trial:

Request an Annual Quote

Dirk van den Boom

CombiMatrix has appointed Dirk van den Boom to its board of directors. Dirk most recently served as president, CEO, and director of Sequenom, prior to its acquisition by LabCorp in September 2016. During his 18 year tenure at Sequenom, he held positions of increasing responsibility including chief scientific and strategy officer, executive VP of research and development, chief technology officer, and senior VP of research and development.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more